Sandra E. Peterson is an Operating Partner at CD&R LLP (Clayton. See sector focus and contact routes.
Sandra E. Peterson is an Operating Partner at CD&R LLP (Clayton, Dubilier & Rice) who joined the firm in 2019 and focuses on healthcare and consumer investments across North America and Europe. She previously served as Group Worldwide Chairman of Johnson & Johnson and has assumed the role of Chair on the M2GEN board following CD&R’s investment in the oncology data company. Her investment thesis centers on the healthcare and consumer sectors, with geographic activity in both North America and Europe, though specific stage preferences and check sizes are not publicly detailed. A notable portfolio company linked to her leadership is M2GEN, an innovative oncology data and informatics firm backed by CD&R, Merck GHI, and McKesson Ventures. She also serves as Microsoft’s Lead Independent Director, a role she began in March 2023, reflecting her broader governance and strategic oversight experience beyond CD&R. No public writing or distinctive point of view specific to her CD&R investment philosophy has been documented in available sources.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in New York.
Investors like Sandra E. Peterson · Full investor directory · Investor access · Company funding database